Abstract:Background The prediction of severe acute pancreatitis (SAP) is the key to providing timely and targeted intensive care for acute pancreatitis (AP). The heart is one of multiple organs involved in the early stage of SAP, but the predictive ability of cardiac dysfunction for SAP remains elusive. We sought to determine if the serum levels of three cardiac indicators (CI) including N-terminal pro-brain natriuretic peptide (NT-proBNP), cardiac troponin I (cTNI), and creatine kinase myocardial band (CK-MB) at admission could predict the occurrence of SAP and the development of related organ failure (OF). Methods A retrospective, single-center cohort study was conducted on the files of patients presenting to the emergency intensive care unit and medical ward of a regional hospital in Shanghai. Patients diagnosed as having AP and who met the 2012 Atlanta guideline were admitted within 48 hours after disease onset. Results Of the 670 AP patients screened, 238 were enrolled into the study and divided into mild acute pancreatitis (MAP) (n=59), moderate severe acute pancreatitis (MSAP) (n=123), and SAP (n=56) groups. No significant difference was found in baseline age, gender, duration from disease onset to admission, comorbidity, or substance abuse. As the levels of three CIs were significantly higher in the SAP group than in the MAP and MSAP groups, the enrolled patients were regrouped into non-SAP and SAP groups for predictive evaluation. Multivariate analysis and nomogram modelling showed that CK-MB, but not cTNI or NT-proBNP predicted the occurrence of SAP [area under curve (AUC) =0.805, confidence interval (CI): 0.794–0.905]. Specifically, 89 patients with OF (Modified Marshall score ≥2) upon admission were selected and CK-MB was shown to predict (AUC =0.805, CI: 0.794–0.905) persistent OF (n=48, duration of OF >48 hours) compared to transient organ failure (TOF) (n=41, duration of OF <48 hours). Conclusions CIs including NT-proBNP, cTNI, and CK-MB were elevated in the early stage of AP. CK-MB might be used as an efficient predictive biomarker for SAP occurrence and OF development at admission.

Cardiac troponin I in acute pancreatitis patients and its influencing factors

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Dynamics of Plasma Troponin I in Acute Myocardial Injury Patients Following Road Traffic Trauma and Relationship with Injury Severity Score and Acute Physiology and Chronic Health Evaluation

Impacts of Atherosclerotic Plaque Composition and Platelet Aggregation on Serum Cardiactroponin T Elevation after Percutaneous Coronary Interventions

Study on the Changes of Plasma Levels of Brain natriureticpeptide(BNP) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Relationship Between the High-Sensitivity C-reactive Protein,cardiac Troponin I and Severity of Coronary Lesion

The predictive effect of myocardial injury markers on the severity of acute pancreatitis

Plasma Level Of Thrombomodulin Is An Early Indication Of Pancreatic Necrosis In Patients With Acute Pancreatitis

Analysis of Influencing Factors Related to Elevated Serum Troponin I Level for COVID-19 Patients in Yichang, China.

Study on etiology of high-sensitivity myocardial troponin T increase in patients with non-acute myocardial infarction

Relationship Between Serum Procalcitonin，high Mobility Group Box Chromoso(m)al Protein 1 Levels and Severity and Prognosis of Acute Pancreatitis

Elevated CK-MB levels are associated with adverse clinical outcomes in acute pancreatitis: a propensity score-matched study

Characteristics of Elevated Cardiac Troponin I in Patients with Acute Ischemic Stroke

Cardiac Indicator CK-MB Might Be a Predictive Marker for Severity and Organ Failure Development of Acute Pancreatitis

Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase

Clinical Significance of Plasma Cardiac Troponin Ⅰ and Brain Natriuretic Peptide Level Measurements in Different Gender Patients with Angina Pectoris

Clinical Significance of Cardiac Troponin-T Elevation after Percutaneous Coronary Intervention

Diagnostic and Progn, Ostic Value of Minor Elevated Cardiac Troponin Levels for Percutaneous Coronary Intervention-Related Myocardial Injury： a Prospective, Single-Center and Double-Blind Study

Diagnostic value of hematological parameters in acute pancreatitis

Levels of Procalcitonin in Blood and Tissue of Acute Pancreatitis Rats

Application of Enhanced Cardiac Troponin Ⅰ Determination in Clinical Diagnosis of Acute Coronary Syndrome